MediWound (MDWD) Tops Q1 EPS by 1c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
MediWound Reports First Quarter 2021 Financial Results
May 5, 2021 7:00 AM EDTFirst Quarter Revenues of $5.8 Million, an Increase of 32% Year-over-Year
Conference call begins today at 8:30 am ET
YAVNE, Israel, May 05, 2021 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation bio-therapeutics solutions for tissue repair and regeneration, today announced financial results for the first quarter ended March 31, 2021.
First Quarter and recent weeks Financial and Business Highlights:
Total revenues for the first quarter of 2021 were $5.8 million, an... More


